Abiogenesis Clinpharm

Executive Summary

Abiogenesis Clinpharm Private Limited is a well-established contract research organization (CRO) headquartered in Hyderabad, India, with over two decades of experience in providing end-to-end clinical trial services. The company serves a broad spectrum of therapeutic areas, including oncology, immunology, endocrinology, dermatology, and infectious diseases, among others. Leveraging a network of clinical sites across India and parts of Asia and Africa, Abiogenesis offers comprehensive solutions such as clinical operations, data management, biostatistics, regulatory affairs, and pharmacovigilance. Its focus on real-world evidence studies and a diversified client base spanning drugs, biologics, vaccines, and medical devices positions it as a reliable partner for global pharmaceutical companies seeking cost-effective trial execution in emerging markets. With a moderate employee range of 200-500 and a private status, the company operates in a competitive CRO landscape but benefits from its regional expertise and long-standing operational track record.

Upcoming Catalysts (preview)

• Q3 2026Major New Client Contract Announcement70% success
• Q4 2026Expansion into New African Markets60% success
• Q2 2026Regulatory Accreditation for Key Service Line75% success